Integra Medsciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 29 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
About Integra Medsciences
Integra Medsciences Private Limited (IMPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 August 1995 and has a history of 29 years and five months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Service Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Girish Haldipur and Sujata Haldipur serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U33125MH1995PTC091483
-
Company No.
091483
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Aug 1995
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Integra Medsciences Private Limited offer?
Integra Medsciences Private Limited offers a wide range of products and services, including Autoclaves, Sterilizers & Incubators, Medical Refrigerator Systems, Enclosures & Cabinets, Flameproof Enclosure, Paper & Paper Made Products, Kraft Paper, Ultra Low Deep Freezer, Safety Cabinets, Clean Room Equipment, Laminar Air Flow.
Who are the key members and board of directors at Integra Medsciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girish Haldipur
|
Director | 07-Aug-1995 | Current |
|
Sujata Haldipur
|
Director | 07-Aug-1995 | Current |
Financial Performance of Integra Medsciences.
Integra Medsciences Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Integra Medsciences?
In 2017, Integra Medsciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Integra Medsciences?
Unlock and access historical data on people associated with Integra Medsciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Integra Medsciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Integra Medsciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.